Plain-English translation of NCT07186699 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a listening and learning study, not a treatment trial. Researchers want to understand the real-world experiences of people who have been diagnosed with non-small cell lung cancer and have a history of alcohol or substance use disorder. By hearing directly from patients about what helped or made it harder to get screened, diagnosed, and treated, the study aims to identify ways to improve care for this group.
People with a history of substance use or alcohol use sometimes face extra barriers to getting cancer screening, diagnosis, and treatment. This study exists to learn what those barriers are—and what helps—so doctors and hospitals can provide better, more personalized care.
You likely qualify if…
You likely don't qualify if…
You would meet with a researcher for one semi-structured interview (like a conversation with guided questions) that lasts about 30 to 60 minutes. You may also be invited to participate in a follow-up group discussion where the researchers share what they've learned so far and ask for your feedback. The interviews are designed to be flexible and conversational so you can share your story in your own words.
AI-generated summary from trial data · Aug 1, 2026 · Not medical advice
United States
Sponsor
University of Southern California
Collaborators
National Cancer Institute (NCI)
Enrollment target
~45 participants
Started
September 2025
Primary completion
September 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.